Skip to content

Clinical trials

Pituitary ACTH Hypersecretion trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pituitary ACTH Hypersecretion Country / region: Netherlands Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20132
20142
20161
20182
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Corcept Therapeutics3
Cortendo AB2
Novartis Pharmaceuticals2
RECORDATI GROUP2
University Hospital, Basel, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pituitary ACTH Hypersecretion10
Cushing Syndrome4
ACTH Syndrome, Ectopic3
Diabetes Mellitus, Type 23
Hypertension3
Adrenal Cortex Neoplasms2
Adrenocortical Carcinoma2
Adrenocortical Hyperfunction2
Pituitary Neoplasms2
Acromegaly1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.